Nyumbani › Limfoma › Texas › Dallas
Majaribio ya kliniki ya Limfoma katika Dallas, TX
Masomo 10 ya Limfoma yanatafuta washiriki katika vituo vya Dallas na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
InaajiriHatua 1/2
- Baylor Scott & White Research Institute, Texas Oncology, Dallas
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
InaajiriHatua 1/2
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
InaajiriHatua 1/2
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
InaajiriHatua 1/2
- Baylor Scott & White Health, Dallas
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
InaajiriHatua 1/2
- Baylor University Medical Center, Dallas
DALY II USA/ MB-CART2019.1 for DLBCL
InaajiriHatua 2
- UT Southwestern Medical Center, Dallas
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
InaajiriHatua 1/2
- Call for Information (Investigational Site 0054), Dallas
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
InaajiriUtafiti wa uchunguzi
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
InaajiriHatua 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
InaajiriHatua 1
- UT Southwestern Medical Center, Dallas
Majaribio ya Limfoma katika miji mingine
- Houston, TXUtafiti 34
- Boston, MAUtafiti 33
- New York City, NYUtafiti 33
- Washington, DCUtafiti 23
- Baldwin Park, CAUtafiti 21
- Chicago, ILUtafiti 20
- Durham, NCUtafiti 17
- St. Louis, MOUtafiti 15
- Philadelphia, PAUtafiti 15
- Cleveland, OHUtafiti 14
- Edison, NJUtafiti 12
- Atlanta, GAUtafiti 12
Masomo mengine katika Dallas
- Saratani ya MatitiUtafiti 55
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 52
- Saratani ya MetastasiUtafiti 42
- Kushindwa kwa MoyoUtafiti 42
- Saratani (aina zote)Utafiti 37
- Saratani ya ProstateUtafiti 36
- Kansari ya kolorektaliUtafiti 33
- UnenepuUtafiti 30
- Kansari ya MayaiUtafiti 28
- Saratani ya MkojoUtafiti 27
- Saratan ya MapafuUtafiti 27
- Saratani ya EndometrialUtafiti 24
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.